ANCC Adult-Gero Review Test 2023

ANCC Adult-Gero Review Test 2023 Acute cough - ANS-< 3 weeks Subacute cough - ANS-3-8 weeks Chronic cough - ANS->8 weeks Acute Bronchitis - ANS-inflammation of the bronchioles Acute bronchitis etiology - ANS-almost always viral Acute Bronchitis symptoms - ANS-cough that usually lasts 10-20 days Acute Bronchitis Treatment - ANS-OTC antitussive, NSAIDs, antibiotics NOT recommended Pneumonia etiology - ANS-*S. pneumoniae *M. pneumoniae *C. pneumoniae Pneumonia treatment - ANS-*healthy with no recent antibiotics=macrolide or doxy *comorbidities or recent antibiotic=DRSP=resp quinolone OR beta-lactam + macrolide OR beta-lactam +Doxy Pneumonia length of treatment - ANS-*minimum 5 days *average 5-10 days *re-evaluate after 48-72 hrs if poor response Pneumovax - ANS-*PPSV: 19-64 with increased risk *PCV13 + PPSV23: all adults >/= 65, or 19-64 with asplenia, immunocompromised, CSF leaks, cochlear implant, advanced CKD COPD - ANS-persistent airflow limitation that is usually progressive and associated with enhanced chronic inflammatory response in the airways and lung to noxious particles or gases COPD Diagnosis - ANS-*symptoms compatible with COPD (DOE, cough, sputum) *spirometry=FEV1/FVC ration <70% plus FEV1 <80% predicted *no alternative explanation for symptoms *Alpha-1 antitrypsin deficiency COPD Stage 1 - ANS-Mild: FEV1/FVC <70%, with or without symptoms COPD Stage 2 - ANS-Moderate: FEV1/FVC <70%, dyspnea with exertion, with or without cough and sputum production Continues...